Blood Purification in Critical Care: Acute Kidney Injury and Beyond
A special issue of Journal of Personalized Medicine (ISSN 2075-4426). This special issue belongs to the section "Personalized Critical Care".
Deadline for manuscript submissions: closed (15 September 2023) | Viewed by 181
Special Issue Editors
Interests: acute kidney injury; continuous renal replacement therapy (CRRT); blood purification
Interests: acute kidney injury; continuous renal replacement therapy (CRRT); blood purification
Special Issue Information
Dear Colleagues,
Acute kidney injury (AKI) is a well-known risk factor with an unfavorable prognosis in critically ill patients, who may require blood purification such as hemodialysis or CRRT. In recent decades, the concept of blood purification is no longer restricted to the field of renal replacement therapy but rather a set of comprehensive treatments for multiple organ dysfunction as well as the removal of pathogenic substances from blood circulation. Classical CRRT in combination with hybrid techniques such as hemoperfusion, blood adsorption, plasmapheresis, and DPMAS has been widely applied in various conditions including sepsis, liver failure, hyperlipidemia, autoimmune disease crisis, etc. In addition, extracorporeal carbon dioxide removal (ECCO2R) on the platform of the CRRT machine has also gained ground as an alternative respiratory support during hypercapnia. The application and optimization of critical care blood purification in AKI and beyond is the focus of research.
Dr. Ling Zhang
Dr. Yuliang Zhao
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Personalized Medicine is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
critical care
acute kidney injury
multiple organ dysfunction
blood purification
continuous renal replacement therapy
hybrid technique